Skip to main content
Equibles

BAILARD, INC.

Position in DFTX — Definium Therapeutics, Inc.

CIK 750641 Foster City, CA
Back to DFTX Full portfolio

Position in DFTX

as of Jun 30, 2026 · filed Jul 30, 2026
Position Value
$295,270
+$295,270 QoQ
Shares Held
6,277
-57.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#256
of 360 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DFTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BAILARD, INC. holds $23,164,134 across 15 Biotechnology names. DFTX ranks #4 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 37,314 $18,534,983
2 REGN
Regeneron Pharmaceuticals, Inc.
 3,376 $2,105,071
3 LGND
Ligand Pharmaceuticals Inc
 1,400 $442,526
4 DFTX
Definium Therapeutics, Inc.
This page 		6,277 $295,270
5 INVA
Innoviva, Inc.
 10,933 $248,288
6 ERAS
Erasca, Inc.
 13,146 $240,834
7 ZVRA
Zevra Therapeutics, Inc.
 14,700 $210,798
8 ARTV
Artiva Biotherapeutics, Inc.
 20,700 $200,790

All Filings in DFTX

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-06-30 $295,270 6,277